These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24239650)

  • 1. IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.
    Stenger EO; Rosborough BR; Mathews LR; Ma H; Mapara MY; Thomson AW; Turnquist HR
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):192-201. PubMed ID: 24239650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells.
    Macedo C; Turnquist HR; Castillo-Rama M; Zahorchak AF; Shapiro R; Thomson AW; Metes D
    Am J Transplant; 2013 Sep; 13(9):2322-33. PubMed ID: 24034707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
    Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
    Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.
    Capitini CM; Nasholm NM; Duncan BB; Guimond M; Fry TJ
    J Immunol; 2013 Feb; 190(3):1351-9. PubMed ID: 23275602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.
    Turnquist HR; Cardinal J; Macedo C; Rosborough BR; Sumpter TL; Geller DA; Metes D; Thomson AW
    Blood; 2010 Jun; 115(23):4758-69. PubMed ID: 20335217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
    Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
    Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody.
    Noble A; Leggat JA; Inderberg EM
    Immunology; 2003 Aug; 109(4):476-86. PubMed ID: 12871213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.
    Schliesser U; Chopra M; Beilhack A; Appelt C; Vogel S; Schumann J; Panov I; Vogt K; Schlickeiser S; Olek S; Wood K; Brandt C; Volk HD; Sawitzki B
    Eur J Immunol; 2013 Dec; 43(12):3291-305. PubMed ID: 23946112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
    Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
    Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.
    Williams CA; Harry RA; McLeod JD
    Immunology; 2008 May; 124(1):89-101. PubMed ID: 18067553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
    Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
    Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.
    Gaignage M; Marillier RG; Uyttenhove C; Dauguet N; Saxena A; Ryffel B; Michiels T; Coutelier JP; Van Snick J
    Immun Inflamm Dis; 2017 Jun; 5(2):200-213. PubMed ID: 28474504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.
    Foley JE; Jung U; Miera A; Borenstein T; Mariotti J; Eckhaus M; Bierer BE; Fowler DH
    J Immunol; 2005 Nov; 175(9):5732-43. PubMed ID: 16237064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.
    Rojas-Canales D; Krishnan R; Jessup CF; Coates PT
    Clin Exp Immunol; 2012 Mar; 167(3):447-58. PubMed ID: 22288588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.